Griffith University is bidding a grateful farewell to community champion and Director of the Institute for Glycomics, Professor Mark von...
Four teams of expert scientists from Griffith University’s Institute for Glycomics are targeting the virus SARS-CoV-2 to discover new vaccines...
Director and Head of Research for the Institute for Glycomics Professor Mark von Itzstein AO has been honoured with the Gold Coast Citizen of the Year award.
Griffith's Institute for Glycomics has partnered with China Grand Pharma’s new Australian company Grand Medical Ltd to develop a drug to treat millions of people with respiratory illnesses.
Professor Mark von Itzstein, Founder and Director of Griffith University’s Institute for Glycomics, has been awarded one of Australia’s highest...
Founder and Director of Griffith University’s Institute for Glycomics, says he is humbled by his inclusion in the Queen's Birthday Honours List.
A multi-million dollar investment by Griffith University to establish a world leading cancer research centre is now challenging traditional approaches to cancer testing and treatments.
Griffith’s Institute for Glycomics have made a promising discovery in the treatment and prevention of human parainfluenza virus.
Foremost Australian medical researchers, Professor Mark von Itzstein and Professor Michael Good from Griffith’s Institute for Glycomics have been honoured with election to Fellowship in the Australian Academy of Health & Medical Science.
Healthscope, Australia's largest provider of integrated healthcare will fund Griffith University research into melanoma.
